Alex S Befeler MD
Advanced Endoscopic Interventional, Hepatology & Liver Transplantation
Professor of Internal Medicine, Saint Louis University Medical Director of Liver Transplantation
Join to view full profile
1225 S Grand BlvdFl 3St. Louis, MO 63104
Phone+1 314-257-3760
Fax+1 314-257-3761
Dr. Befeler is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Alex Befeler, MD is a gastroenterologist and hepatologist based in St Louis, Missouri with subspecialties in hepatology & liver transplantation. His education includes a fellowship in gastroenterology at the University of Chicago, and a residency in internal medicine at the University of Texas Southwestern Medical Center. Dr. Befeler has experience in hepatology and has participated in several clinical trials, including one on bariatric embolization of arteries in obese patients with HCC to allow for salvage liver transplantation. He has authored numerous publications within his field, with his works frequently cited by other clinicians. In 2014, he was recognized as a Regional Top Doctor by Castle Connolly.
Education & Training
University of ChicagoFellowship, Gastroenterology, 1995 - 1998
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1992 - 1995
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1992
Certifications & Licensure
IL State Medical License 1995 - 2029
MO State Medical License 1998 - 2027
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation Start of enrollment: 2017 Oct 18
Publications & Presentations
PubMed
- 13 citationsPhase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in Cirrhosis.Naoto Fujiwara, Camden Lopez, Tracey L Marsh, Indu Raman, Cesia A Marquez
Gastroenterology. 2025-03-01 - 64 citationsA Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis.Tracey L Marsh, Neehar D Parikh, Lewis R Roberts, Myron E Schwartz, Mindie H Nguyen
Gastroenterology. 2025-02-01 - Outcomes of kidney, liver, and simultaneous liver and kidney transplants from hepatitis c infected donors to hepatitis c naïve recipients: A large single center experi...Hany Elbeshbeshy, Neal Modi, Twinkle Patel, Ian Matthews, Timothy Kampert
Clinical Transplantation. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: